Epigenetic regulation of indoleamine-2,3-dioxygenase 1 expression in human breast cancer

被引：0
|
作者：
Dewi, D. L. [1 ]
Mohapatra, S. [1 ]
Wimberger, P. [2 ,3 ,4 ,5 ]
Kuhlmann, J. D. [2 ,3 ,4 ,5 ]
Schott, S. [6 ]
Kellner, K. -H. [7 ]
Gerhaeuser, C. [8 ]
Trump, S. [9 ]
Opitz, C. A. [1 ,10 ,11 ]
机构：
[1] German Canc Res Ctr, Brain Canc Metab Grp, Heidelberg, Germany
[2] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Gynecol & Obstet, Dresden, Germany
[3] Natl Ctr Tumor Dis NCT Dresden, Dresden, Germany
[4] German Canc Consortium DKTK, Dresden, Germany
[5] German Canc Res Ctr, Dresden, Germany
[6] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany
[7] Neuroimmun GmbH, Karlsruhe, Germany
[8] German Canc Res Ctr, Epigen & Canc Risk Factors, Heidelberg, Germany
[9] Helmholtz Ctr Environm Res, Dept Environm Immunol, Leipzig, Germany
[10] Univ Heidelberg Hosp, Neurol Clin, Heidelberg, Germany
[11] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
BREAST | 2017年 / 32卷
关键词：
D O I：
10.1016/S0960-9776(17)30128-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P027
引用
收藏
页码：S31 / S32
页数：2
相关论文
共 50 条
  • [31] Indoleamine-2,3-dioxygenase and Interleukin-6 associated with tumor response to neoadjuvant chemotherapy in breast cancer
    Li, Fangxuan
    Wei, Lijuan
    Li, Shixia
    Liu, Juntian
    ONCOTARGET, 2017, 8 (64) : 107844 - 107858
  • [32] STATUS OF INDOLEAMINE-2,3-DIOXYGENASE 1 IN INFILTRATING DUCTAL CARCINOMA OF BREAST CANCER: A NEW PROGNOSTIC INDICATOR FOR AGGRESSIVE TUMORS
    Salmi, T.
    Dali-Sahi, M.
    Guermouche, B.
    Dennouni-Medjati, N.
    Hennart, B.
    Lenski, M.
    Allorge, D.
    WORLD CANCER RESEARCH JOURNAL, 2021, 8
  • [33] Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells
    Ebokaiwe, Azubuike Peter
    Njoya, Emmanuel Mfotie
    Sheng, Yuwen
    Zhang, Zhonghui
    Li, Sheng
    Zhou, Zongyuan
    Qiang, Zhe
    Peng, Ting
    Hussein, Ahmed A.
    Zhang, Guolin
    Lu, Xiaoxia
    Li, Lin
    Wang, Fei
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 404
  • [34] Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors
    Singh, Rahul
    Salunke, Deepak B.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 211
  • [35] Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice
    Aslamkhan, Amy G.
    Xu, Qiuwei
    Loughlin, Amy
    Vu, Heather
    Pacchione, Stephen
    Bhatt, Bhavana
    Garfinkel, Ivy
    Styring, Tara Grady
    LaFranco-Scheuch, Lisa
    Pearson, Kara
    Reynolds, Spencer
    Li, Nianyu
    Zhou, Heather
    Miller, J. Richard
    Solban, Nicolas
    Bass, Alan
    Glaab, Warren E.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 406
  • [36] Clinical Significance of Program Death Ligand-1 and Indoleamine-2,3-Dioxygenase Expression in Colorectal Carcinoma
    Hacking, Sean
    Vitkovski, Taisia
    Jain, Swachi
    Jin, Cao
    Chavarria, Hector
    Wu, Dongling
    Nasim, Mansoor
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (03) : 201 - 208
  • [37] Understanding the role of indoleamine-2,3-dioxygenase and stromal differentiation in rare subtype endometrial cancer
    Wu, Dongling
    Hacking, Sean
    Cao, Jin
    Nasim, Mansoor
    RARE TUMORS, 2021, 13
  • [38] Expression and purification of recombinant human indoleamine 2,3-dioxygenase
    Littlejohn, TK
    Takikawa, O
    Skylas, D
    Jamie, JF
    Walker, MJ
    Truscott, RJW
    PROTEIN EXPRESSION AND PURIFICATION, 2000, 19 (01) : 22 - 29
  • [39] Correlation of Indoleamine-2,3-Dioxygenase and Chronic Kidney Disease: A Pilot Study
    Pan, Binbin
    Zhang, Feng
    Sun, Jian
    Chen, Dawei
    Huang, Wenjuan
    Zhang, Hao
    Cao, Changchun
    Wan, Xin
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [40] Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
    Stefan Löb
    Alfred Königsrainer
    Hans-Georg Rammensee
    Gerhard Opelz
    Peter Terness
    Nature Reviews Cancer, 2009, 9 : 445 - 452
12345